CLOSE

Dialog Box

Loading...

The Latest News

Eli Lilly and Company has announced the expansion of an existing immuno-oncology collaboration with Merck, to add a new study of Lilly's LARTRUVO™ with KEYTRUDA® in patients with previously treated advanced or metastatic soft tissue sarcoma (STS). More

Researchers from QUT are seeking participation of Queensland and Victorian adults with terminal cancer and their family members in a study exploring medical decision-making by and for people with cancer. More

Upcoming events

Rare Cancers Australia hosts a vareity of events throughout the year in support of rare cancer awareness. Come along and support our work. See all events.

Campaigns & Fundraising

Support Rare Cancers Australia by donating to a campaign, a fundraiser, or even by setting up your own fundraising page! Find out more.